Literature DB >> 21996374

Dysregulation of microRNAs in adrenocortical tumors.

Puneet Singh1, Patsy S H Soon, Jean-Jacques Feige, Olivier Chabre, Jing Ting Zhao, Nadia Cherradi, Enzo Lalli, Stan B Sidhu.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs that are involved in the epigenetic regulation of cellular processes. Different malignancies are often associated with the deregulation of specific sets of miRNAs. The prognosis of adrenocortical cancers (ACCs) is very poor as compared to adrenocortical adenomas (ACAs), and even within ACCs there are cases with better disease specific survival. An improved understanding of the pathobiology of this disease will therefore be useful in facilitating better management of ACCs as well as distinguishing high risk versus low risk subgroups. One third of coding genes are regulated by miRNAs and therefore changes in miRNA expression may be associated with cancer development and progression. In this review we summarize the current understanding of miRNAs in adrenocortical tumors, and highlight their potential in differentiating between ACCs and ACAs, risk stratification and prognosis. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21996374     DOI: 10.1016/j.mce.2011.09.041

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

1.  MicroRNA-34a negatively regulates anesthesia-induced hippocampal apoptosis and memory impairment through FGFR1.

Authors:  Xiu-Li Jiang; Bo-Xiang Du; Jie Chen; Lin Liu; Wei-Bin Shao; Jie Song
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.

Authors:  Mauro Papotti; Eleonora Duregon; Marco Volante; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 3.  Molecular markers of adrenocortical tumors.

Authors:  Meenu Jain; Nesrin Rechache; Electron Kebebew
Journal:  J Surg Oncol       Date:  2012-04-13       Impact factor: 3.454

Review 4.  Noncoding RNAs in endocrine malignancy.

Authors:  Jessica Kentwell; Justin S Gundara; Stan B Sidhu
Journal:  Oncologist       Date:  2014-04-09

Review 5.  Circulating miRNAs as biomarkers for endocrine disorders.

Authors:  H Butz; N Kinga; K Racz; A Patocs
Journal:  J Endocrinol Invest       Date:  2015-05-28       Impact factor: 4.256

6.  MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors.

Authors:  Dhaval Patel; Myriem Boufraqech; Meenu Jain; Lisa Zhang; Mei He; Krisana Gesuwan; Neelam Gulati; Naris Nilubol; Tito Fojo; Electron Kebebew
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

7.  In silico analysis of pathways affected by differentially expressed microRNA in adrenocortical tumors.

Authors:  A Zsippai; P M Szabó; D R Szabó; Z Nagy; A Patócs; K Rácz; P Igaz
Journal:  J Endocrinol Invest       Date:  2013-07-01       Impact factor: 4.256

Review 8.  5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.

Authors:  Enzo Lalli; Hironobu Sasano
Journal:  Horm Cancer       Date:  2015-12-14       Impact factor: 3.869

Review 9.  Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors.

Authors:  Enzo Lalli; Bonald C Figueiredo
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-18       Impact factor: 5.555

10.  MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway.

Authors:  Xiangxiang Shan; Yufeng Miao; Rengen Fan; Haixin Qian; Ping Chen; Hongqi Liu; Xiaomei Yan; Jianping Li; Fen Zhou
Journal:  Int J Mol Sci       Date:  2013-04-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.